Increase in hemokinin-1 mRNA in the spinal cord during the early phase of a neuropathic pain state

British Journal of Pharmacology

Volumn 155, Issue 5, 2008, Pages 767-774

  Matsumura, T ^a   Sakai, A ^b   Nagano, M ^b   Sawada, M ^c   Suzuki, H ^b,c   Umino, M ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b NIPPON MEDICAL SCHOOL   (Japan)

^c NAGOYA UNIVERSITY   (Japan)

Author keywords

Chronic constrictive injury; Dorsal root ganglion; Hemokinin 1; Microglial cell; Neuropathic pain; Spinal cord; Substance P; TAC1; TAC4; Tachykinin

Indexed keywords

HEMOKININ 1; MESSENGER RNA; MINOCYCLINE; SUBSTANCE P; TACHYKININ DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; GENE; GENE EXPRESSION; LUMBAR SPINE; MALE; MICROGLIA; NERVE INJURY; NEUROPATHIC PAIN; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SCIATIC NERVE; SPINAL CORD; SPINAL GANGLION; TAC1 GENE; TAC4 GENE;

ANIMALS; CELL LINE; DISEASE MODELS, ANIMAL; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; LUMBOSACRAL REGION; MALE; MICROGLIA; MINOCYCLINE; PAIN THRESHOLD; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SCIATICA; SPINAL CORD; TACHYKININS;

EID: 54949089187     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/bjp.2008.301     Document Type: Article

References (42)

1. Alexander SPH, Mathie A, Peters JA (2008). Guide to receptors and channels (GRAC), 3rd edn. Br J Pharmacol 153 (Suppl. 2): S1-S209.
2. Basbaum AI (1999). Spinal mechanisms of acute and persistent pain. Reg Anesth Pain Med 24: 59-67.
3. Bennett GJ, Xie YK (1988). A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33: 87-107.
4. Block ML, Li G, Qin L, Wu X, Pei Z, Wang T et al. (2006). Potent regulation of microglia-derived oxidative stress and dopaminergic neuron survival: substance P vs dynorphin. FASEB J 20: 251-258.
5. Covino BG, Dubner R, Gybels J, Kosterlitz HW, Liebeskind JC, Sternbach RA et al. (1980). Ethical standards for investigations of experimental pain in animals. Pain 9: 141-143.
6. Duffy RA, Hedrick JA, Randolph G, Morgan CA, Cohen-Williams ME, Vassileva G et al. (2003). Centrally administered hemokinin-1 (HK-1), a neurokinin NK1 receptor agonist, produces substance P-like behavioral effects in mice and gerbils. Neuropharmacology 45: 242-250.
7. Endo D, Ikeda T, Ishida Y, Yoshioka D, Nishimori T (2006). Effect of intrathecal administration of hemokinin-1 on the withdrawal response to noxious thermal stimulation of the rat hind paw. Neurosci Lett 392: 114-117.
8. Gehrmann J, Banati RB (1995). Microglial turnover in the injured CNS: activated microglia undergo delayed DNA fragmentation following peripheral nerve injury. J Neuropathol Exp Neurol 54: 680-688.
9. Hanisch UK, Kettenmann H (2007). Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci 10: 1387-1394.
10. Hill R (2000). NK1 (substance P) receptor antagonists-why are they not analgesic in humans? Trends Pharmacol Sci 21: 244-246.
11. Jin SX, Zhuang ZY, Woolf CJ, Ji RR (2003). p38 mitogen-activated protein kinase is activated after a spinal nerve ligation in spinal cord microglia and dorsal root ganglion neurons and contributes to the generation of neuropathic pain. J Neurosci 23: 4017-4022.
12. Kurtz MM, Wang R, Clements MK, Cascieri MA, Austin CP, Cunningham BR et al. (2002). Identification, localization and receptor characterization of novel mammalian substance P-like peptides. Gene 296: 205-212.
13. Ling EA, Kaur LC, Yick TY, Wong WC (1990). Immunocytochemical localization of CR3 complement receptors with OX-42 in amoeboid microglia in postnatal rats. Anat Embryol (Berl) 182: 481-486.
14. Mantyh PW, Hunt SP (2004). Setting the tone: superficial dorsal horn projection neurons regulate pain sensitivity. Trends Neurosci 27: 582-584.
15. Marchand JE, Wurm WH, Kato T, Kream RM (1994). Altered tachykinin expression by dorsal root ganglion neurons in a rat model of neuropathic pain. Pain 58: 219-231.
16. Milligan ED, Twining C, Chacur M, Biedenkapp J, O'Connor K, Poole S et al. (2003). Spinal glia and proinflammatory cytokines mediate mirror-image neuropathic pain in rats. J Neurosci 23: 1026-1040.
17. Nagano M, Saitow F, Haneda E, Konishi S, Hayashi M, Suzuki H (2006). Distribution and pharmacological characterization of primate NK-1 and NK-3 tachykinin receptors in the central nervous system of the rhesus monkey. Br J Pharmacol 147: 316-323.
18. Nagano M, Sakai A, Takahashi N, Umino M, Yoshioka K, Suzuki H (2003). Decreased expression of glial cell line-derived neurotrophic factor signaling in rat models of neuropathic pain. Br J Pharmacol 140: 1252-1260.
19. Nakaya Y, Kaneko T, Shigemoto R, Nakanishi S, Mizuno N (1994). Immunohistochemical localization of substance P receptor in the central nervous system of the adult rat. J Comp Neurol 347: 249-274.
20. Naono R, Yoshioka D, Ikeda T, Nakayama T, Nishimori T (2007). The common carboxyl-terminal region of novel tachykinin peptides contributes to induce desensitization in scratching behavior of rats. Brain Res Bull 71: 461-465.
21. Nelson DA, Marriott I, Bost KL (2004). Expression of hemokinin 1 mRNA by murine dendritic cells. J Neuroimmunol 155: 94-102.
22. Nichols ML, Allen BJ, Rogers SD, Ghilardi JR, Honore P, Luger NM et al. (1999). Transmission of chronic nociception by spinal neurons expressing the substance P receptor. Science 286: 1558-1561.
23. Otsuka M, Yoshioka K (1993). Neurotransmitter functions of mammalian tachykinins. Physiol Rev 73: 229-308.
24. Page NM (2004). Hemokinins and endokinins. Cell Mol Life Sci 61: 1652-1663.
25. Patacchini R, Lecci A, Holzer P, Maggi CA (2004). Newly discovered tachykinins raise new questions about their peripheral roles and the tachykinin nomenclature. Trends Pharmacol Sci 25: 1-3.
26. Pocock JM, Kettenmann H (2007). Neurotransmitter receptors on microglia. Trends Neurosci 30: 527-535.
27. Rasley A, Bost KL, Olson JK, Miller SD, Marriott I (2002). Expression of functional NK-1 receptors in murine microglia. Glia 37: 258-267.
28. Rupniak NMJ, Kramer MS (1999). Discovery of the antidepressant and anti-emetic efficacy of substance P receptor (NK1) antagonists. Trends Pharmacol Sci 20: 485-490.
29. Salimi K, Moser K, Zassler B, Reindl M, Embacher N, Schermer C et al. (2002). Glial cell line-derived neurotrophic factor enhances survival of GM-CSF dependent rat GMIR1-microglial cells. Neurosci Res 43: 221-229.
30. Scholz J, Woolf CJ (2007). The neuropathic pain triad: neurons, immune cells and glia. Nat Neurosci 10: 1361-1368.
31. Severini C, Improta G, Falconieri-Erspamer G, Salvadori S, Erspamer V (2002). The tachykinin peptide family. Pharmacol Rev 54: 285-322.
32. Snijdelaar DG, Dirksen R, Slappendel R, Crul BJ (2000). Substance P. Eur J Pain 4: 121-135.
33. Tikka T, Fiebich BL, Goldsteins G, Keinänen R, Koistinaho J (2001). Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. J Neurosci 21: 2580-2588.
34. Tikka TM, Koistinaho JE (2001). Minocycline provides neuroprotection against N-Methyl-D-aspartate neurotoxicity by inhibiting microglia. J Immunol 166: 7527-7533.
35. Tsuda M, Inoue K, Salter MW (2005). Neuropathic pain and spinal microglia: a big problem from molecules in 'small' glia. Trends Neurosci 28: 101-107.
36. Wang AL, Yu ACH, Lau LT, Lee C, Wu LM, Zhu X et al. (2005). Minocycline inhibits LPS-induced retinal microglia activation. Neurochem Int 47: 152-158.
37. Woolf CJ, Salter MW (2000). Neuronal plasticity: Increasing the gain in pain. Science 288: 1765-1768.
38. Yrjänheikki J, Keinänen R, Pellikka M, Hökfelt T, Koistinaho J (1998). Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc Natl Acad Sci USA 95: 15769-15774.
39. Yune TY, Lee JY, Jung GY, Kim SJ, Jiang MH, Kim YC et al. (2007). Minocycline alleviates death of oligodendrocytes by inhibiting pro-nerve growth factor production in microglia after spinal cord injury. J Neurosci 27: 7751-7761.
40. Zhang Y, Paige CJ (2003). T-cell developmental blockage by tachykinin antagonists and the role of hemokinin 1 in T lymphopoiesis. Blood 102: 2165-2172.
41. Zhang Y, Lu L, Furlonger C, Wu GE, Paige CJ (2000). Hemokinin is a hematopoietic-specific tachykinin that regulates B lymphopoiesis. Nat Immunol 1: 392-397.
42. Zhuang ZY, Kawasaki Y, Tan PH, Wen YR, Huang J, Ji RR (2007). Role of the CX3CR1/p38 MAPK pathway in spinal microglia for the development of neuropathic pain following nerve injury-induced cleavage of fractalkine. Brain Behav Immun 21: 642-651.